SCHEMBL7550562

SCHEMBL7550562

Cc1ccsc1C(O)C(=O)c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.41
PTGS1 P23219 3/20 0.39
CES2 O00748 4/20 0.37
CES1 P23141 4/20 0.37
PTGS2 P35354 1/20 0.37
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CYP1A2 P05177 2/20 0.35
RBBP9 O75884 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7642306 0.74 ALOX5 (0.49) ALOX5CYP1A2CYP2D6L3MBTL1
SCHEMBL7087828 0.71 SMN1; SMN2 (0.37) CES2CES1CA1CA2SLC6A2
SCHEMBL11468486 0.70 ALOX5 (0.45) ALOX5CYP1A2CYP2C19KDM4E
SCHEMBL15680018 0.70 CES2 (0.63) CES2CES1CA1CA2KDM4E
SCHEMBL5444935 0.70 CES2 (0.63) CES2CES1CA1CA2KDM4E
SCHEMBL29077329 0.68 CES2 (0.52) CES2CES1CA1CA2SLC6A2
SCHEMBL4869727 0.68 CES2 (0.52) CES2CES1CA1CA2SLC6A2
SCHEMBL835861 0.67 CES2 (0.56) CES2CES1CA1CA2SLC6A2
SCHEMBL9588015 0.67 ALOX5 (0.35) ALOX5SLC6A3CYP2C19KDM4E
SCHEMBL7087822 0.67 CES2 (0.50) ALOX5CES2CES1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 US disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO disclosed